Utama › Kanser (semua jenis) › Virginia
Kajian klinikal Kanser (semua jenis) di Virginia
71 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi di Virginia.
Bandar di Virginia
Teks kajian rasmi (Bahasa Inggeris)
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- NEXT Virginia, Fairfax
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07529808A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Next Virginia /ID# 279684, Fairfax
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 1 Okt 2026 · NCT07024784A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
- Virginia Cancer Specialists ( Site 1102), Fairfax
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07209111A Study of ASP3082 in Adults With Advanced Solid Tumors
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05382559Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Virginia Oncology Associates, Norfolk
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07566156REC-7735 in Participants With Solid Tumors
- NEXT Virginia, Fairfax
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07819136Registry Study for Radiation Therapy Outcomes
- Inova Schar Cancer Institute, Fairfax
- Hampton University Proton Therapy Institute, Hampton
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 29 Sep 2026 · NCT01255748A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT07127874Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Inova Schar Cancer Institute, Fairfax
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07195591A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
- NEXT Oncology, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07612176A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Inova Schar Cancer Institute Clinical Trials, Fairfax
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 3, Charlottesville
Mengambil pesertaFasa 3
Umur 18 hingga 71 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Blue Ridge Cancer Care - Blacksburg /ID# 281583, Blacksburg
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax
- Shenandoah Oncology /ID# 280699, Winchester
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07365241Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- NEXT Oncology Virginia, Fairfax
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06128551TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Inova Schar Cancer Institute, Fairfax
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University Of Virginia Health System, Charlottesville
Mengambil pesertaFasa 2/3
Semua umur · Semua jantina · Dikemas kini 18 Sep 2026 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UVA Center for Psychiatric Clinical Research, Charlottesville
Mengambil pesertaFasa 2
Umur 18 hingga 80 · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07002034The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Westchester Emergency Center, Midlothian
- Bon Secours Saint Francis Medical Center, Midlothian
- dan 3 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT06756607A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- NEXT Virginia ( Site 0054), Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07247110A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- Virginia Commonwealth University ( Site 1008), Richmond
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06818643Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site number: 404, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Lelaki · Dikemas kini 10 Sep 2026 · NCT05997615A Phase 1/1b Study of IAM1363 in HER2 Cancers
- NEXT Oncology - Virginia Cancer Specialists, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06253871A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- NEXT Oncology, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06440005Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Virginia Cancer Institute, Norfolk
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT05386108A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Midlothian
Mengambil pesertaFasa 3
Umur 18 hingga 130 · Semua jantina · Dikemas kini 8 Sep 2026 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of Virginia Health System, Charlottesville
- USO - Virginia Cancer Specialists, Fairfax
- VCU Health Adult Outpatient Pavillion, Richmond
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 8 Sep 2026 · NCT06119581Prostate Active Surveillance Study
- Eastern Virginia Medical School, Norfolk
Mengambil pesertaKajian pemerhatian
Umur 21 ke atas · Lelaki · Dikemas kini 2 Sep 2026 · NCT00756665Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Hematology-Oncology Associates of Fredericksburg, Inc, Fredericksburg
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06072612A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- NEXT Virginia, Fairfax
Mengambil pesertaFasa 1
Umur 18 hingga 99 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06983743A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- NEXT Oncology, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07321106A Study of ARC-02 in B-cell NHL
- Massey Cancer Center, Richmond
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07691606Project: Every Child for Younger Patients With Cancer
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- dan 3 lagi
Mengambil pesertaKajian pemerhatian
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- University of Virginia Health System, Charlottesville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 19 Ogo 2026 · NCT04104776FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT05919264A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
- NEXT Oncology Virginia, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06759649Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06580314A Study of ASP1002 in Adults for Treatment of Solid Tumors
- NEXT Oncology Virginia, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jul 2026 · NCT05719558Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 522, Fairfax
- 300, Norfolk
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 16 Jul 2026 · NCT06906341A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Virginia Cancer Specialists, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Jul 2026 · NCT06657144A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Jul 2026 · NCT05650632Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.